Germline FH mutations presenting with pheochromocytoma - PubMed
- ️Invalid Date
. 2014 Oct;99(10):E2046-50.
doi: 10.1210/jc.2014-1659. Epub 2014 Jul 8.
Marco Sciacovelli, Edoardo Gaude, Diana M Walsh, Gail Kirby, Michael A Simpson, Richard C Trembath, Jonathan N Berg, Emma R Woodward, Esther Kinning, Patrick J Morrison, Christian Frezza, Eamonn R Maher
Affiliations
- PMID: 25004247
- DOI: 10.1210/jc.2014-1659
Germline FH mutations presenting with pheochromocytoma
Graeme R Clark et al. J Clin Endocrinol Metab. 2014 Oct.
Abstract
Context: At least a third of the patients with pheochromocytoma (PCC) or paraganglioma (PGL) harbor an underlying germline mutation in a known PCC/PGL gene. Mutations in genes (SDHB, SDHD, SDHC, and SDHA) encoding a component of the tricarboxylic acid cycle, succinate dehydrogenase (SDH), are a major cause of inherited PCC and PGL. SDHB mutations are also, albeit less frequently, associated with inherited renal cell carcinoma. Inactivation of SDH and another tricarboxylic acid cycle component, fumarate hydratase (FH), have both been associated with abnormalities of cellular metabolism, responsible for the activation of hypoxic gene response pathways and epigenetic alterations (eg, DNA methylation). However, the clinical phenotype of germline mutations in SDHx genes and FH is usually distinct, with FH mutations classically associated with hereditary cutaneous and uterine leiomyomatosis and renal cell carcinoma, although recently an association with PCC/PGL has been reported.
Objective and design: To identify potential novel PCC/PGL predisposition genes, we initially undertook exome resequencing studies in a case of childhood PCC, and subsequently FH mutation analysis in a further 71 patients with PCC, PGL, or head and neck PGL.
Results: After identifying a candidate FH missense mutation in the exome study, we then detected a further candidate missense mutation (p.Glu53Lys) by candidate gene sequencing. In vitro analyses demonstrated that both missense mutations (p.Cys434Tyr and p.Glu53Lys) were catalytically inactive.
Conclusions: These findings 1) confirm that germline FH mutations may present, albeit rarely with PCC or PGL; and 2) extend the clinical phenotype associated with FH mutations to pediatric PCC.
Similar articles
-
Udager AM, Magers MJ, Goerke DM, Vinco ML, Siddiqui J, Cao X, Lucas DR, Myers JL, Chinnaiyan AM, McHugh JB, Giordano TJ, Else T, Mehra R. Udager AM, et al. Hum Pathol. 2018 Jan;71:47-54. doi: 10.1016/j.humpath.2017.10.013. Epub 2017 Oct 24. Hum Pathol. 2018. PMID: 29079178
-
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
Castro-Vega LJ, Buffet A, De Cubas AA, Cascón A, Menara M, Khalifa E, Amar L, Azriel S, Bourdeau I, Chabre O, Currás-Freixes M, Franco-Vidal V, Guillaud-Bataille M, Simian C, Morin A, Letón R, Gómez-Graña A, Pollard PJ, Rustin P, Robledo M, Favier J, Gimenez-Roqueplo AP. Castro-Vega LJ, et al. Hum Mol Genet. 2014 May 1;23(9):2440-6. doi: 10.1093/hmg/ddt639. Epub 2013 Dec 13. Hum Mol Genet. 2014. PMID: 24334767
-
Fuchs TL, Luxford C, Clarkson A, Sheen A, Sioson L, Elston M, Croxson MS, Dwight T, Benn DE, Tacon L, Field M, Ahadi MS, Chou A, Clifton-Bligh RJ, Gill AJ. Fuchs TL, et al. Am J Surg Pathol. 2023 Jan 1;47(1):25-36. doi: 10.1097/PAS.0000000000001945. Epub 2022 Aug 22. Am J Surg Pathol. 2023. PMID: 35993574 Free PMC article.
-
Müller U. Müller U. Neurogenetics. 2011 Aug;12(3):175-81. doi: 10.1007/s10048-011-0280-y. Epub 2011 Mar 9. Neurogenetics. 2011. PMID: 21547462 Review.
-
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.
Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, Pacak K. Timmers HJ, et al. Endocr Relat Cancer. 2009 Jun;16(2):391-400. doi: 10.1677/ERC-08-0284. Epub 2009 Feb 3. Endocr Relat Cancer. 2009. PMID: 19190077 Free PMC article. Review.
Cited by
-
Casey RT, Warren AY, Martin JE, Challis BG, Rattenberry E, Whitworth J, Andrews KA, Roberts T, Clark GR, West H, Smith PS, Docquier FM, Rodger F, Murray V, Simpson HL, Wallis Y, Giger O, Tran M, Tomkins S, Stewart GD, Park SM, Woodward ER, Maher ER. Casey RT, et al. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4013-4022. doi: 10.1210/jc.2017-00562. J Clin Endocrinol Metab. 2017. PMID: 28973655 Free PMC article. Review.
-
Toledo RA, Dahia PL. Toledo RA, et al. Curr Opin Endocrinol Diabetes Obes. 2015 Jun;22(3):169-79. doi: 10.1097/MED.0000000000000150. Curr Opin Endocrinol Diabetes Obes. 2015. PMID: 25871962 Free PMC article. Review.
-
Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI, Hakimi AA, Stewart GD, Bratslavsky G, Brugarolas J, Chen YB, Linehan WM, Maher ER, Merino MJ, Offit K, Reuter VE, Shuch B, Coleman JA. Carlo MI, et al. Eur Urol. 2019 Dec;76(6):754-764. doi: 10.1016/j.eururo.2019.06.015. Epub 2019 Jul 18. Eur Urol. 2019. PMID: 31326218 Free PMC article.
-
Oncometabolites in renal cancer.
Yong C, Stewart GD, Frezza C. Yong C, et al. Nat Rev Nephrol. 2020 Mar;16(3):156-172. doi: 10.1038/s41581-019-0210-z. Epub 2019 Oct 21. Nat Rev Nephrol. 2020. PMID: 31636445 Free PMC article. Review.
-
Gieldon L, William D, Hackmann K, Jahn W, Jahn A, Wagner J, Rump A, Bechmann N, Nölting S, Knösel T, Gudziol V, Constantinescu G, Masjkur J, Beuschlein F, Timmers HJ, Canu L, Pacak K, Robledo M, Aust D, Schröck E, Eisenhofer G, Richter S, Klink B. Gieldon L, et al. Cancers (Basel). 2019 Jun 11;11(6):809. doi: 10.3390/cancers11060809. Cancers (Basel). 2019. PMID: 31212687 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous